Trulieve Cannabis (TCNNF) Income from Continuing Operations (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Income from Continuing Operations of 3361000.0 in Q1 2026, up 107.48% quarter-over-quarter from 44948000.0 in Q4 2025, and up 110.46% on a YoY basis from 1596990.57 in Q1 2025.
Trulieve Cannabis (TCNNF) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 3361000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 110.46% year-over-year to 3361000.0; the TTM figure through Mar 2026 stood at 81138000.0 (up 50.38% YoY), while the FY2025 annual figure was 116636000.0, up 24.69% from the prior year.
- Income from Continuing Operations was 3361000.0 for Q1 2026 at Trulieve Cannabis, up from 44948000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3361000.0 in Q1 2026 to a low of 342076000.0 in Q2 2023.
- Historically, Income from Continuing Operations has averaged 52341294.12 across 5 years, with a median of 32137000.0 in 2025.
- The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations sank 1720.81% in 2023, then jumped 110.46% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 64221000.0 in 2022, then surged by 43.0% to 36603000.0 in 2023, then plunged by 65.21% to 60473000.0 in 2024, then increased by 25.67% to 44948000.0 in 2025, then soared by 107.48% to 3361000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3361000.0 (Q1 2026), 44948000.0 (Q4 2025), and 23735000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 3.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.36 Mn |
| Dec 31, 2025 | -44.95 Mn |
| Sep 30, 2025 | -23.74 Mn |
| Jun 30, 2025 | -15.82 Mn |
| Mar 31, 2025 | -32.14 Mn |
| Dec 31, 2024 | -60.47 Mn |
| Sep 30, 2024 | -60.22 Mn |
| Jun 30, 2024 | -10.69 Mn |
| Mar 31, 2024 | -23.49 Mn |
| Dec 31, 2023 | -36.60 Mn |
| Sep 30, 2023 | -22.92 Mn |
| Jun 30, 2023 | -342.08 Mn |
| Mar 31, 2023 | -34.30 Mn |
| Dec 31, 2022 | -64.22 Mn |
| Sep 30, 2022 | -72.63 Mn |
| Jun 30, 2022 | -18.79 Mn |
| Mar 31, 2022 | -30.12 Mn |
| Dec 31, 2021 | -59.05 Mn |
| Sep 30, 2021 | 18.62 Mn |
| Jun 30, 2021 | 40.88 Mn |